People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Biotech / Pharma, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pivotal Systems Corp | — | Other Technology | Series A | $32.4M | $151.8M | 2009 |
| Araceli Biosciences Inc. | — | Biotech / Pharma | Series A | $14.5M | $50.4M | 2024 |
| Nexx Systems Inc | — | Manufacturing | Seed | $5.2M | $15.3M | 2009 |
| Columbia Nutritional, LLC | — | Manufacturing | Seed | $4.2M | $10.9M | 2018 |
| Nanometrics Inc | — | Other Technology | Seed | $4.0M | $135.6M | 2018 |
Bruce Rhine at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce Rhine on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Eibl | 2 | 5 |
| Kevin Gabelein | 2 | 4 |
| David Johnson | 1 | 35 |
| Andrew Smith | 1 | 14 |
| Sean O'Neill | 1 | 5 |
| Kevin Landis | 1 | 5 |
| J. William Freytag | 1 | 4 |
| Anthony Chang | 1 | 4 |
| Omesh Sharma | 1 | 3 |
| John Hoffman | 1 | 3 |
| Christine A. Tsingos | 1 | 2 |
| Timothy J. Stultz | 1 | 2 |
| Matt Beaudet | 1 | 2 |
| Kirk Malloy | 1 | 2 |
| Richard Post | 1 | 2 |
| Edward J. Brown, Jr. | 1 | 2 |
| Kevin Heidrich | 1 | 2 |
| Pierre-Yves Lesaicherre | 1 | 2 |
| Binh Do | 1 | 2 |
| J. Thomas Bentley | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.